ATE491722T1 - Herstellung und reinigung von il-29 - Google Patents

Herstellung und reinigung von il-29

Info

Publication number: ATE491722T1
Authority: AT; Austria
Prior art keywords: methods; production; purification; coli; vectors
Prior art date: 2005-10-04

Application number

AT06816409T

Other languages

English (en)

Inventor

Bruce Zamost

Geoffrey Lee

Robert Dedinsky

Original Assignee

Zymogenetics L L C

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-04

Filing date

2006-10-04

Publication date

2011-01-15

2006-10-04 Application filed by Zymogenetics L L C, Bristol Myers Squibb Co filed Critical Zymogenetics L L C

2011-01-15 Application granted granted Critical

2011-01-15 Publication of ATE491722T1 publication Critical patent/ATE491722T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Ultra Sonic Daignosis Equipment (AREA)
Separation Of Suspended Particles By Flocculating Agents (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT06816409T 2005-10-04 2006-10-04 Herstellung und reinigung von il-29 ATE491722T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US72354405P	2005-10-04	2005-10-04
PCT/US2006/039139 WO2007041713A1 (en)	2005-10-04	2006-10-04	Production and purification of il-29

Publications (1)

Publication Number	Publication Date
ATE491722T1 true ATE491722T1 (de)	2011-01-15

Family

ID=37603659

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06816409T ATE491722T1 (de)	2005-10-04	2006-10-04	Herstellung und reinigung von il-29

Country Status (15)

Country	Link
US (6)	US20080096252A1 (de)
EP (1)	EP1931704B1 (de)
JP (3)	JP5364375B2 (de)
AT (1)	ATE491722T1 (de)
AU (1)	AU2006299339B2 (de)
CA (1)	CA2625208A1 (de)
CY (1)	CY1112323T1 (de)
DE (1)	DE602006018969D1 (de)
DK (1)	DK1931704T3 (de)
ES (1)	ES2357152T3 (de)
IL (2)	IL189994A (de)
PL (1)	PL1931704T3 (de)
PT (1)	PT1931704E (de)
SI (1)	SI1931704T1 (de)
WO (1)	WO2007041713A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001296962A1 (en)	2000-09-29	2002-04-08	Schering Corporation	Pegylated interleukin-10
US7038032B2 (en)	2001-04-20	2006-05-02	Zymogenetics, Inc.	Cytokine protein family
WO2005023862A2 (en) *	2003-08-07	2005-03-17	Zymogenetics, Inc.	Homogeneous preparations of il-28 and il-29
JP4987001B2 (ja) *	2005-07-20	2012-07-25	ザイモジェネティクスリミテッドライアビリティカンパニー	癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
AU2006269908A1 (en) *	2005-07-20	2007-01-25	Bristol-Myers Squibb Company	IL28 and IL29 truncated cysteine mutants and antiviral methods of using same
DK1931704T3 (da)	2005-10-04	2011-03-14	Zymogenetics L L C	Frembringelse og rensning af IL-29
CL2008002053A1 (es)	2007-07-17	2009-05-22	Hoffmann La Roche	Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
AR067536A1 (es) *	2007-07-17	2009-10-14	Hoffmann La Roche	Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
WO2009036510A1 (en) *	2007-09-20	2009-03-26	Commonwealth Scientific And Industrial Research Organisation	Novel avian cytokines and genetic sequences encoding same
US20110034672A1 (en) *	2008-01-18	2011-02-10	Roberto Falkenstein	Purification of not-glycosylated polypeptides
WO2009149377A1 (en)	2008-06-05	2009-12-10	Zymogenetics, Llc	Use of pegylated type iii interferons for the treatment of hepatitis c
DK2350271T3 (en)	2008-11-20	2016-04-04	Biogen Ma Inc	ARGININ INACTIVATION OF ENVIRONMENT VIRA
US8691205B2 (en)	2008-12-17	2014-04-08	Merck Sharp & Dohme Corporation	Mono- and di-PEG IL-10 production; and uses
CN102459569B (zh) *	2009-04-10	2018-02-23	Reg生命科学有限责任公司	脂肪酸衍生物的产生
EP2535057A2 (de)	2010-02-09	2012-12-19	Proyecto de Biomedicina Cima, S.L.	Zusammensetzung zur behandlung von infektions- und tumorerkrankungen
JP5768341B2 (ja) *	2010-08-04	2015-08-26	東ソー株式会社	Ｆｃ結合性タンパク質の製造方法
CN102584979B (zh) *	2011-01-18	2015-10-14	北京凯因科技股份有限公司	PEG化干扰素λ
US10201584B1 (en)	2011-05-17	2019-02-12	Abbvie Inc.	Compositions and methods for treating HCV
WO2013028233A1 (en) *	2011-08-25	2013-02-28	Nanogen Pharmaceutical Biotechnology	Peg-interferon lambda 1 conjugates
US8454947B1 (en)	2012-03-01	2013-06-04	Nanogen Pharmaceutical Biotechnology	PEG-interferon lambda 1 conjugates
RU2549710C2 (ru) *	2012-06-29	2015-04-27	Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства (ФГБУ "ГНЦ Институт иммунологии" ФМБА России)	Способ очистки рекомбинантного белка интерфероноподобного фактора iii типа
JP6086378B2 (ja) *	2012-11-30	2017-03-01	国立大学法人お茶の水女子大学	組み換えヒト膵臓リパーゼの調製方法
CN104045704B (zh) *	2013-03-11	2016-08-10	中国医学科学院基础医学研究所	PEG化重组人IFN-λ1、其制备方法和用途
CN105209054A (zh)	2013-04-18	2015-12-30	阿尔莫生物科技股份有限公司	使用白细胞介素-10治疗疾病和病症的方法
AU2014281828B2 (en)	2013-06-17	2019-05-09	Armo Biosciences, Inc.	Method for assessing protein identity and stability
US20160159853A1 (en) *	2013-07-19	2016-06-09	Biogenomics Limited	Apparatus for refolding of recombinant proteins
JP6509867B2 (ja)	2013-08-30	2019-05-08	アルモ・バイオサイエンシーズ・インコーポレイテッド	疾患及び障害を治療するためにインターロイキン−１０を使用する方法
JP6660297B2 (ja)	2013-11-11	2020-03-11	アルモ・バイオサイエンシーズ・インコーポレイテッド	疾患及び障害を処置するためのインターロイキン−１０の使用方法
JP6730926B2 (ja) *	2014-01-08	2020-07-29	プロージットソウルバイオテクノロジー（ベイジン）カンパニーリミテッド	融合ポリペプチドおよび使用方法
US10076512B2 (en)	2014-05-01	2018-09-18	Eiger Biopharmaceuticals, Inc.	Treatment of hepatitis delta virus infection
US11311519B2 (en)	2014-05-01	2022-04-26	Eiger Biopharmaceuticals, Inc.	Treatment of hepatitis delta virus infection
WO2015187295A2 (en)	2014-06-02	2015-12-10	Armo Biosciences, Inc.	Methods of lowering serum cholesterol
JP2017536098A (ja)	2014-10-14	2017-12-07	アルモ・バイオサイエンシーズ・インコーポレイテッド	インターロイキン−１５組成物及びその使用
ES2941234T3 (es)	2014-10-22	2023-05-19	Armo Biosciences Inc	Métodos de uso de la interleucina-10 para el tratamiento de enfermedades y trastornos
EP3237441A4 (de) *	2014-12-23	2018-06-06	Armo Biosciences, Inc.	Verfahren zur verbesserung des ertrags in der produktion rekombinanter proteine
WO2016126615A1 (en)	2015-02-03	2016-08-11	Armo Biosciences, Inc.	Methods of using interleukin-10 for treating diseases and disorders
WO2016172342A1 (en)	2015-04-21	2016-10-27	Eiger Biopharmaceuticals, Inc.	Pharmaceutical compositions comprising lonafarnib and ritonavir
CN107847583A (zh)	2015-05-28	2018-03-27	阿尔莫生物科技股份有限公司	用于治疗癌症的聚乙二醇化白细胞介素‑10
KR20180038553A (ko)	2015-08-25	2018-04-16	아르모 바이오사이언시스 인코포레이티드	질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
US10953072B2 (en)	2016-02-19	2021-03-23	Eiger Biopharmaceuticals, Inc.	Treatment of hepatitis delta virus infection with interferon lambda
JP7073363B2 (ja) *	2016-11-07	2022-05-23	シージェンインコーポレイテッド	工学的に操作されたシステインキャップの分配
EP3927733A4 (de)	2019-02-24	2022-07-06	Oncosimis Biotech Private Limited	Verfahren zur kontinuierlichen herstellung von rekombinantem glp-1-peptid durch bakterien

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4795077A (en) *	1988-05-23	1989-01-03	Motorola Inc.	Bonding method and apparatus
EP0626448A3 (de) *	1993-05-26	1998-01-14	BOEHRINGER INGELHEIM INTERNATIONAL GmbH	Verfahren zur Herstellung und Reinigung von alpha-Interferon
JP2002531089A (ja) *	1998-11-30	2002-09-24	イーライ・リリー・アンド・カンパニー	赤血球産生性化合物
CZ299516B6 (cs) *	1999-07-02	2008-08-20	F. Hoffmann-La Roche Ag	Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
DK1294888T3 (da) *	2000-06-30	2007-08-20	Zymogenetics Inc	Interferonlignende protein Zcyto21
US7038032B2 (en) *	2001-04-20	2006-05-02	Zymogenetics, Inc.	Cytokine protein family
AU2003286624B2 (en) *	2002-10-23	2008-11-13	Bristol-Myers Squibb Company	Methods for treating viral infection using IL-28 and IL-29
MXPA05006117A (es) *	2002-12-13	2005-09-30	Zymogenetics Inc	Produccion de il-21 en hospederos procarioticos.
WO2005023862A2 (en) *	2003-08-07	2005-03-17	Zymogenetics, Inc.	Homogeneous preparations of il-28 and il-29
US20050244423A1 (en) *	2004-04-02	2005-11-03	Klucher Kevin M	Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
US7351689B2 (en) *	2004-07-29	2008-04-01	Zymogenetics, Inc.	Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
CN1305902C (zh) *	2004-11-25	2007-03-21	汕头大学医学院	一种人白细胞介素29的生产方法及重组il－29工程菌
SI1828239T1 (sl) *	2004-12-10	2011-11-30	Zymogenetics Inc	Proizvodnja fgf18 v prokariotskih gostiteljih
JP4987001B2 (ja) *	2005-07-20	2012-07-25	ザイモジェネティクスリミテッドライアビリティカンパニー	癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
DK1931704T3 (da)	2005-10-04	2011-03-14	Zymogenetics L L C	Frembringelse og rensning af IL-29

2006
- 2006-10-04 DK DK06816409.4T patent/DK1931704T3/da active
- 2006-10-04 DE DE602006018969T patent/DE602006018969D1/de active Active
- 2006-10-04 AT AT06816409T patent/ATE491722T1/de active
- 2006-10-04 EP EP06816409A patent/EP1931704B1/de active Active
- 2006-10-04 AU AU2006299339A patent/AU2006299339B2/en active Active
- 2006-10-04 PL PL06816409T patent/PL1931704T3/pl unknown
- 2006-10-04 SI SI200630952T patent/SI1931704T1/sl unknown
- 2006-10-04 ES ES06816409T patent/ES2357152T3/es active Active
- 2006-10-04 WO PCT/US2006/039139 patent/WO2007041713A1/en active Application Filing
- 2006-10-04 PT PT06816409T patent/PT1931704E/pt unknown
- 2006-10-04 JP JP2008534712A patent/JP5364375B2/ja active Active
- 2006-10-04 CA CA002625208A patent/CA2625208A1/en not_active Abandoned
- 2006-10-04 US US11/538,688 patent/US20080096252A1/en not_active Abandoned
2008
- 2008-03-06 IL IL189994A patent/IL189994A/en active IP Right Grant
2009
- 2009-08-07 US US12/537,935 patent/US7759092B2/en active Active
2010
- 2010-02-05 US US12/701,358 patent/US7968315B2/en active Active
2011
- 2011-03-11 CY CY20111100270T patent/CY1112323T1/el unknown
- 2011-05-24 US US13/114,566 patent/US8211670B2/en active Active
2012
- 2012-06-05 US US13/488,840 patent/US20120271037A1/en not_active Abandoned
- 2012-08-01 JP JP2012170709A patent/JP2012235789A/ja active Pending
- 2012-12-19 US US13/720,363 patent/US8759027B2/en active Active
- 2012-12-27 JP JP2012284581A patent/JP2013099337A/ja active Pending
2013
- 2013-07-29 IL IL227691A patent/IL227691A0/en unknown

Also Published As

Publication number	Publication date
US20100003722A1 (en)	2010-01-07
JP2013099337A (ja)	2013-05-23
WO2007041713A1 (en)	2007-04-12
CY1112323T1 (el)	2015-12-09
IL189994A (en)	2013-08-29
CA2625208A1 (en)	2007-04-12
US20080096252A1 (en)	2008-04-24
US7759092B2 (en)	2010-07-20
JP2009510173A (ja)	2009-03-12
SI1931704T1 (sl)	2011-04-29
IL189994A0 (en)	2008-08-07
PL1931704T3 (pl)	2011-06-30
JP5364375B2 (ja)	2013-12-11
IL227691A0 (en)	2013-09-30
US20100222552A1 (en)	2010-09-02
DE602006018969D1 (de)	2011-01-27
US20130143270A1 (en)	2013-06-06
US20120271037A1 (en)	2012-10-25
AU2006299339B2 (en)	2012-03-15
US20120015403A1 (en)	2012-01-19
US8759027B2 (en)	2014-06-24
EP1931704A1 (de)	2008-06-18
AU2006299339A1 (en)	2007-04-12
DK1931704T3 (da)	2011-03-14
US8211670B2 (en)	2012-07-03
EP1931704B1 (de)	2010-12-15
ES2357152T3 (es)	2011-04-19
US7968315B2 (en)	2011-06-28
JP2012235789A (ja)	2012-12-06
PT1931704E (pt)	2011-03-28

Legal Events

Date

Code

Title

Description

2011-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1931704

Country of ref document: EP

Publication	Publication Date	Title
ATE491722T1 (de)	2011-01-15	Herstellung und reinigung von il-29
ATE492633T1 (de)	2011-01-15	Polypeptide mit cellobiohydrolaseaktivität und dafür kodierende polynukleotide
CY1110860T1 (el)	2015-06-10	Αναστροφη μεταγραφαση τελομερασης πτηνου
ATE515568T1 (de)	2011-07-15	Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
ATE470702T1 (de)	2010-06-15	Verfahren zur herstellung von permanenten humanen zelllinien
BRPI0613770A2 (pt)	2009-05-19	anticorpos anti-cd26 e métodos de uso destes
WO2011150133A3 (en)	2012-03-08	Fibronectin based scaffold proteins having improved stability
EA201270713A1 (ru)	2013-01-30	Белки на основе фибронектина с каркасными доменами, которые связывают ил-23
MX2009012846A (es)	2009-12-14	Polipeptidos que tienen actividad celulosica mejorada y polinucleotidos que los codifican.
WO2010099477A3 (en)	2011-01-06	Polypeptide structural motifs associated with cell signaling activity
BR112012008054A2 (pt)	2017-05-23	domínios catalíticos de lisil oxidase e loxl2
ATE513907T1 (de)	2011-07-15	Polypeptide mit endoglucanase-aktivität und polynukleotide zu ihrer kodierung
TW200740841A (en)	2007-11-01	Polypeptides having antimicrobial activity and polynucleotides encoding same
FI3581650T3 (fi)	2023-03-23	IX-tekijän polypeptidimutantti, sen käyttöjä ja menetelmä sen valmistamiseksi
BR112013003522A8 (pt)	2017-12-26	"polipeptídeos relaxina modificados compreendendo um aminoácido não codificado naturalmente, uso, método de preparação, bem como ácido nucleico codificando os mesmos"
MX339031B (es)	2016-05-05	Peptidos intestinales vasoactivos modificados.
DE602006010051D1 (de)	2009-12-10	Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
EA200701592A1 (ru)	2008-04-28	Композиты и способы их получения и использования
EA201300056A1 (ru)	2013-07-30	Полипептид с активностью ацетилксиланэстеразы и его применения
EA201300057A1 (ru)	2013-05-30	Полипептид, обладающий углеводдеградирующей активностью, и его применения
TW200734350A (en)	2007-09-16	Polypeptides having antimicrobial activity and polynucleotides encoding same
BRPI0515904A (pt)	2008-08-12	processo para purificar uma mistura gasosa compreendendo monóxido de dinitrogênio, uso de uma mistura gasosa, e, processo para preparar uma cetona
EA201300059A1 (ru)	2013-05-30	Полипептид, обладающий активностью сволленина, и его применение
TW200700076A (en)	2007-01-01	Polypeptides having antimicrobial activity and polynucleotides encoding same
AR051489A1 (es)	2007-01-17	Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que los codifican